LYTIR

Insider · SEC Form 4 · Director, 10% Owner

CHOO CHEE KONG

Filed with the SEC as Choo Chee Kong; the order above is the one the filer's own signature uses.

In the 12 months to Nov 8, 2026, on the open market: bought $429K of GDTC. Filed a median of 8 business days after the trade.

Open-market purchases and sales this filer reported on SEC Form 4, by the day traded. Insiders have two business days to file. A sale marked 10b5-1 was made under a plan adopted in advance. How to read these

Insider purchases and sales, by month (last 12 months)Insider purchases: $429K in total; Insider sales: $0 in total.May: Insider purchases $129KJul: Insider purchases $300KDecJanFebMarAprMayJunJulAugSepOctNov
Insider purchases above the line: $429KInsider sales below: $0
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.
  1. GDTCBought: CytoMed Therapeutics Ltd Jul 20, 2026 100,000 shares filed Jul 24, 2026 630,324 shares held directly after, as filed filing $150K
  2. GDTCBought: CytoMed Therapeutics Ltd Jul 14, 2026 100,000 shares filed Jul 24, 2026 530,324 shares held directly after, as filed filing $150K
  3. GDTCBought: CytoMed Therapeutics Ltd May 13, 2026 112,000 shares filed Jun 15, 2026 430,324 shares held directly after, as filed filing $129K

Source: SEC Form 4 filings. Value is shares × the price reported on the filing; a filing whose price failed Lytir's check against the market price is left out, and a trade that related owners reported on separate forms is counted once. Filings can be late, amended or wrong at the source; see methodology.